A Phase 1 Randomized, Controlled, Double-Blind, Single Ascending Dose Safety and Pharmacokinetic/Pharmacodynamic Study in Healthy Adult Males After LIQ865 Injection
Phase of Trial: Phase I
Latest Information Update: 24 May 2017
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Adverse reactions; First in man
- 24 May 2017 Results published in a Liquidia Technologies media release.
- 06 Feb 2017 Status changed from not yet recruiting to recruiting.
- 09 Dec 2016 New trial record